At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
Shockwave Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Market Clinical Follow Up Study to Collect Additional Data and Imaging
In Brief
A clinical study evaluating Shockwave Treatment for Connective Tissue Defect. Completed, enrolled 5 participants across 1 site.
Detailed Summary
This is a prospective, open label, multi-center clinical study to collect additional data and imaging for the ViaSure device.The intended use of the ViaSure device used in this study is to assess the usability and tissue response to shock wave treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConnective Tissue Defect
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedMay 2021
Primary CompletionMay 2021
TodayJul 2026
First PostedMay 10, 2021
Enrollment StartMar 12, 2021
Primary CompletionMay 11, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.1 years ago
Interventions
Shockwave Treatmentdevice
Self-controlled, single-arm group using the Shockwave device.